Comparing the current results to its competitors, Telesis Bio Inc reported Revenue decrease in the 3 quarter 2024 year on year by -68.66 %, despite the revenue increase by the most of its competitors of 0.72 %, recorded in the same quarter.
Telesis Bio Inc 's Comment on Competition and Industry Peers
The company operates in a competitive and rapidly evolving market characterized by technological advancements and changing customer demands. Its competitors include core synthetic biology firms and companies within the broader next-generation sequencing (NGS) sector. These competitors specialize in various aspects of synthetic biology applications, including gene synthesis, enzymatic DNA synthesis, protein engineering, cell engineering, tools and automation, software, food and agriculture, materials, aquaculture, biopharmaceuticals, and health. The company identifies a gap in the market for a comprehensive solution that provides end-to-end control of biologics and vaccine discovery and development workflows in-house.
Competitors mentioned in company filings include Aldevron, LLC; Azenta; Danaher Corporation; Eurofins Scientific; Evonetix Ltd.; GenScript Biotech Corporation; Illumina, Inc.; Integrated DNA Technologies, Inc.; Molecular Assemblies, Inc.; Nuclera Nucleics Ltd; Nutcracker Therapeutics, Inc.; Roche AG; SAS; Synthego Corporation; Thermo Fisher Scientific Inc.; TriLink BioTechnologies, Inc.; and Twist Bioscience Corporation.
Agilent Technologies Inc. operates a business model centered on delivering innovative measurement solutions across industries like life sciences, diagnostics, and chemical analysis. Their revenue primarily comes from sales of instruments, software, and consumables, supplemented by support services. The company emphasizes strong partnerships and collaborations to enhance their market presence and influence.
Illumina Inc is a leading company in the genomics sector, focusing on next-generation sequencing technologies that enhance genetic analysis. Their business model encompasses a diverse range of products, including sequencing platforms, reagents, and bioinformatics solutions, which together facilitate comprehensive genomic studies for researchers. By integrating these tools, Illumina supports advancements in fields such as oncology, drug discovery, and personalized healthcare, positioning itself at the forefront of genomic innovation.
Standard Biotools Inc operates as a biotechnology company that specializes in the development and distribution of standard laboratory tools and reagents. They offer a diverse range of high-quality products including lab equipment, molecular diagnostics, and research reagents to meet the needs of scientists and researchers in the life sciences industry. With a customer-centric approach, Standard Biotools aims to provide reliable and affordable solutions to support advancements in scientific research and discovery.
Mettler toledo International Inc Share Performance
-0.79%
30 Days
Mettler toledo International Inc
Profile
Mettler Toledo International Inc. operates on a business model that focuses on providing high-quality precision instruments and solutions tailored for various industries, including pharmaceuticals, food production, and laboratory research. The company emphasizes innovation and customer-centric service, delivering advanced technology and software alongside its instruments to enhance operational efficiency and accuracy. Additionally, Mettler Toledo generates recurring revenue through maintenance services, calibration, and consumables associated with its products, fostering long-term relationships with its clients.
Nautilus Biotechnology Inc's business model focuses on using advanced genomics and proteomics technologies to analyze and understand the human proteome.
Sources:
Telesis Bio Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Telesis Bio Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
